Paige Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 132

Employees

  • Latest Deal Type
  • Series C1

  • Latest Deal Amount
  • $19.5M

  • Investors
  • 11

Paige General Information

Description

Developer of computational pathology module platform designed for rapid diagnostic stratification and cancer detection. The company's platform follows a deep learning algorithm based on convolutional and recurrent neural networks as well as generative models that are focused on breast, prostate, and other major types of cancer, allowing clinical researchers and pathologists to understand the progress of diseases with various mutations for efficient treatment.

Contact Information

Website
www.paige.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11 Times Square
  • 37th Floor
  • New York, NY 10036
  • United States
+1 (347)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 11 Times Square
  • 37th Floor
  • New York, NY 10036
  • United States
+1 (347)

Paige Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paige Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C1) 16-Mar-2023 $19.5M Completed Generating Revenue
3. Later Stage VC (Series C) 08-Mar-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 13-Jul-2020 $70M $95M Completed Generating Revenue
1. Early Stage VC (Series A) 05-Feb-2018 $25M $25M Completed Generating Revenue
To view Paige’s complete valuation and funding history, request access »

Paige Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-1
Series C
Series B
Series A-1 1,223,684 $0.000100 $4.9 $4.9 1x $4.9 4.84%
Series A 5,180,260 $0.000100 $4.9 $4.9 1x $4.9 20.51%
To view Paige’s complete cap table history, request access »

Paige Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of computational pathology module platform designed for rapid diagnostic stratification and cancer detection.
Decision/Risk Analysis
New York, NY
132 As of 2024

Philadelphia, PA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Paige Competitors (17)

One of Paige’s 17 competitors is Proscia, a Private Equity-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Proscia Private Equity-Backed Philadelphia, PA
CureMetrix Venture Capital-Backed San Diego, CA
Boreal Genomics Formerly VC-backed Vancouver, Canada
Inspirata Corporate Backed or Acquired Tampa, FL
PreciseDx Venture Capital-Backed New York, NY
You’re viewing 5 of 17 competitors. Get the full list »

Paige Patents

Paige Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240362865-A1 Systems and methods for processing whole slide images using machine-learning Pending 26-Apr-2023
US-20240177838-A1 Systems and methods for processing electronic images using deep foundation models Pending 29-Nov-2022
US-20240062372-A1 Systems and methods for processing images to determine biomarker levels Pending 18-Aug-2022
US-20230401685-A1 Systems and methods for processing electronic images to identify transplant donor-recipient matches Pending 08-Jun-2022
US-20230386031-A1 Systems and methods to process electronic images for histological morphology trajectory prediction Pending 27-May-2022 G06T7/0012
To view Paige’s complete patent history, request access »

Paige Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paige Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Healthcare Venture Partners Venture Capital Minority
Palkon Capital Management Hedge Fund Minority
Casdin Capital Venture Capital Minority
Catalio Capital Management Venture Capital Minority
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Paige FAQs

  • When was Paige founded?

    Paige was founded in 2017.

  • Where is Paige headquartered?

    Paige is headquartered in New York, NY.

  • What is the size of Paige?

    Paige has 132 total employees.

  • What industry is Paige in?

    Paige’s primary industry is Decision/Risk Analysis.

  • Is Paige a private or public company?

    Paige is a Private company.

  • What is the current valuation of Paige?

    The current valuation of Paige is .

  • What is Paige’s current revenue?

    The current revenue for Paige is .

  • How much funding has Paige raised over time?

    Paige has raised $239M.

  • Who are Paige’s investors?

    Healthcare Venture Partners, Palkon Capital Management, Casdin Capital, Catalio Capital Management, and Johnson & Johnson Innovation - JJDC are 5 of 11 investors who have invested in Paige.

  • Who are Paige’s competitors?

    Proscia, CureMetrix, Boreal Genomics, Inspirata, and PreciseDx are some of the 17 competitors of Paige.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »